CTOs on the Move

BioVentrix

www.bioventrix.com

 
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.bioventrix.com
  • 12647 Alcosta Boulevard Suite 400
    San Ramon, CA USA 94583
  • Phone: 925.830.1000

Executives

Name Title Contact Details

Funding

BioVentrix raised $21.7M on 05/01/2019

Similar Companies

Owlet Baby Care

The world`s first infant health tracker, designed to notify you if your baby`s heart rate or oxygen levels fall out of range. Rest assured with Owlet.

Saringer Life Science Technologies

Saringer Life Science Technologies Inc. is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CONMED Integrated Systems (CMIS)

CONMED Integrated Systems (CMIS) is a Utica, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MLS Logistics

MLS Logistics is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LumiThera

At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.